CompoAtlas

LGS Gut Therapy - Complete and Gentle Acute Care

Texto original en francés.

Producto de salud natural autorizado en Canadá

Si este producto se vendiera en Francia

Solo se calcula una cantidad diaria para una posología oral explícita para adultos, expresada por día y en una unidad sólida correspondiente a la forma del producto. No se extrapolan las unidades ambiguas, los líquidos, los polvos ni las dosis pediátricas. Una cantidad no calculada no se compara con los límites de dosis. Este análisis no constituye una autorización de venta en Francia ni una evaluación de seguridad o eficacia.

Composición

Ingrediente medicinal y fuentePor unidad posológica, según la fuenteMáximo diario, adulto
Bifidobacterium animalis subsp. Lactis

Fuente : Cellule entière

9.280.000.000 ufcNo calculada
Bifidobacterium animalis subsp. Lactis

Fuente : BL-04

9.280.000.000 ufcNo calculada
Protéase fongique

Fuente : Aspergillus flavus var. oryzae - En entier

Potencia : 11.000 FCC HUT

10,45 milligrammeNo calculada
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Fuente : Trichoderma longibrachiatum - En entier

Potencia : 1.800 FCC CU

6,2 milligrammeNo calculada
Triacylglycérol lipase

Fuente : Rhizopus oryzae - En entier

Potencia : 40 FCC LU

0,08 milligrammeNo calculada
Papaïne

Fuente : Carica papaya - fruit

Potencia : 62.500 FCC PU

25 milligrammeNo calculada
Mentha x piperita

Fuente : Extrait de Feuille

Relación de extracción : 10:1

Equivalente de planta seca : 400 milligramme

40 milligrammeNo calculada
Foeniculum vulgare subsp. vulgare var. dulce

Fuente : Seed extract

Relación de extracción : 4:1

Equivalente de planta seca : 400 milligramme

100 milligrammeNo calculada
Lactobacillus plantarum

Fuente : Cellule entière

880.000.000 ufcNo calculada
Lactobacillus plantarum

Fuente : Lp-115

880.000.000 ufcNo calculada
Lactobacillus acidophilus

Fuente : Cellule entière

13.740.000.000 ufcNo calculada
Lactobacillus acidophilus

Fuente : LA-14

13.740.000.000 ufcNo calculada
Huile de poisson

Fuente : Huile du corps d'Anchois

Potencia : 18 % DHA (docosahexaenoic acid)

833,33 milligrammeNo calculada
Huile de poisson

Fuente : Huile du corps d'Anchois

Potencia : 48 % EPA (eicosapentaenoic acid)

No especificadaNo calculada
Curcuma longa

Fuente : Rhizome Extract

Relación de extracción : 4:1

Equivalente de planta seca : 400 milligramme

100 milligrammeNo calculada
Linum usitatissimum L. (Linaceae)

Fuente : Graine(s)

100 milligrammeNo calculada
Bifidobacterium longum subsp. longum

Fuente : Cellule entière

220.000.000 ufcNo calculada
Bifidobacterium longum subsp. longum

Fuente : BI-05

220.000.000 ufcNo calculada
Lactobacillus casei

Fuente : LC-11

440.000.000 ufcNo calculada
Lactobacillus casei

Fuente : Cellule entière

440.000.000 ufcNo calculada
Lactobacillus rhamnosus

Fuente : Cellule entière

440.000.000 ufcNo calculada
Lactobacillus rhamnosus

Fuente : LR-32

440.000.000 ufcNo calculada
Bromélaïne de tige

Fuente : Ananas comosus var. comosus - Tige

Potencia : 600.000 FCC PU

25 milligrammeNo calculada
Inuline

Fuente : Cichorium intybus - racine

2.500 milligrammeNo calculada
L-Glutamine

Fuente : L-Glutamine

2.500 milligrammeNo calculada
Althaea officinalis

Fuente : Racine

250 milligrammeNo calculada
Plantago afra

Fuente : Graine(s)

1.250 milligrammeNo calculada
Acacia

Fuente : Gomme

500 milligrammeNo calculada
Protéase

Fuente : Aspergillus niger - En entier

Potencia : 34 FCC SAPU

6,42 milligrammeNo calculada
4-alpha-D-Glucane glucanohydrolase

Fuente : Aspergillus flavus var. oryzae - Cellule entière

Potencia : 3.700 FCC DU

16,54 milligrammeNo calculada
1,4-alpha-D-Glucane glucohydrolase

Fuente : Aspergillus niger

Potencia : 22 FCC AGU

16,32 milligrammeNo calculada

Ingredientes no medicinales

Huile de tournesol, Hypromellose, Acide citrique, Feuille de stevia rebaudiana, Maltodextrine, Saveur, Dextrine, farine de riz, gomme acacia, Eau purifiée, Dioxyde de silicium, Son de riz, cellulose, Lécithine, Glycérine, bêta-carotène, Cire d'abeille, Gomme de xanthane, Caramel, Gélatine, Carbonate de calcium

Dosis recomendadas en Canadá

PoblaciónEdadCantidad por tomaFrecuencia
AdultesNon précisée1 Capsule, libération retardée1 Tous les jours
AdultesNon précisée3 GéluleNon précisée
AdultesNon précisée2 MesuresNon précisée
AdultesNon précisée1 Capsule3 Tous les jours

Usos autorizados en Canadá

Inflammation Support: Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Used in Herbal Medicine to aid digestion. Used in Herbal Medicine to help relieve flatulent dyspepsia (carminative). Used in Herbal Medicine as a hepatoprotectant / liver protectant. Used in Herbal Medicine to increae bile excretion by the liver (choleretic) and stimulate contraction of the gallbladder (cholagogue). Used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Healing Fibre: (Used in Herbal Medicine as a) bulk-forming laxative. (Used in Herbal Medicine to) promote(s) bowel movements by increasing bulk volume and water content. (Used in Herbal Medicine to) provide(s) gentle relief of constipation and / or irregularity. Helps restore plasma glutamine levels depleted after periods of physical stress (e.g. prolonged exhaustive exercise). Helps support immune system health after periods of physical stress. Helps support digestive system health after periods of physical stress. Helps to assist in muscle cell repair after exercise. Source of fibre for the maintenance of good health. Helps support and maintain a health digestive system. Helps stimulate the growth of healthy bacteria (such as bifidobacteria) in the intestine / gut. Prebiotic. Helps provide gentle relief of constipation and / or irregularity. Acute Care Probiotic: Source of probiotics. Helps support intestinal / gastrointestinal health. Could promote a favourable gut flora. Intensive Enzymes: Digestive enzyme. Digestive aid. Helps digest proteins. Sweet Fennel is traditionally used in Herbal Medicine to help relieve digestive disturbances including bloating and flatulence. Sweet Fennel is traditionally used in Herbal Medicine to help relieve the pain associated with menstruation. Sweet Fennel is traditionally used in Herbal Medicine as an expectorant to help relieve coughs associated with colds. Peppermint is traditionally used in Herbal Medicine to aid digestion (stomachic). Peppermint is traditionally used in Herbal Medicine to help relieve flatulent dyspepsia ( Carminative).

Texto original en inglés.

Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.

Advertencias en Canadá

Cautions and Warnings : Inflammation Support: Consult a health care practitioner prior to use if you are pregnant or have gallstones, a bile duct obstruction, stomach ulcers or excess stomach acid. Consult a health care practitioner if symptoms persist or worsen. Store in an airtight containter, protected from light. Healing Fibre: Take 2 hours before or after taking other medications or natural health products since the absorption of these products may be delayed. Effects observed 12-24 hours after first does, and may take 2-3 days. Consult a health care practitioner if symptoms persist, worsen or if laxative effect does not occur within seven days. Consult a health care practitioner immediately if you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product. Consult a health care practitioner prior to use if you are pregnant or breastfeeding or following a low protein diet or taking medications which inhibit peristaltic movement (e.g. opioids, loperamide) or have diabetes or have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis). Do not use if experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or failure to defaecate following the use of another laxative product or have diabetes mellitus in which blood sugar is difficult to regulate or have difficulty swallowing. Hypersensitivity, such as allergy, has been known to occur due to flaxseed and inulin and also following inhaled and/or ingested psyllium; in which case, discontinue use. May cause mild gastro-intestinal discomfort (such as gas, bloating, cramps). Store in well-closed containers at room temperature. Acute Care Probiotic: If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product. Intensive Enzymes: Consult a health care practitioner for use beyond 2 weeks. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding, have anemia, gallstones, a gastrointestinal lesion/ulcer, diabetes or allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach and tomato), are taking an anticoagulant/blood thinner, anti-nflammatory or antibiotic, or are having surgery. Do not use if you are allergic to anethole or plants of the Apiaceae / Carrot family. Hypersensitivity/allergy has been known to occur ; in which case, discontinue use. Nausea, vomiting and diarrhoea have been known to occur, in which case discontinue use (and consult a health care practitioner).

Texto original en inglés.

Ficha del producto

Otros nombres
LGS Gut Therapy Step 1: Complete and Gentle Acute Care
Titular
Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
NPN o DIN-HM
80077529
Estado
Licencia activa
Fecha de licencia
17 de mayo de 2017
Fecha de revisión
No indicada
Forma
Gélule
Vía de administración
Orale
Tipo de solicitud
Non traditionnelle

Fuente

Ficha oficial de Health Canada, licencia 80077529

Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Texto original en inglés.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Texto original en francés.

La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.

Advertencias oficiales (Health Canada)

Health Canada publica advertencias sobre estos ingredientes:

  • Mentha x piperita
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    PEPPERMINT - MENTHA X PIPERITA

    Vía de administración: Oral

    Precauciones y advertencias

    Condición de aplicación: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).

    Fuentes citadas por Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Condición de aplicación: Essential oil.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    Fuentes citadas por Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Reacciones adversas conocidas

    Condición de aplicación: Essential oil.

    When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    Fuentes citadas por Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).

    Fuentes citadas por Health Canada (2)
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Monografía de Health Canada del 27 de febrero de 2026

  • Foeniculum vulgare subsp. vulgare var. dulce
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    BITTER FENNEL- FOENICULUM VULGARE

    Vía de administración: Oral

    Precauciones y advertencias

    Condición de aplicación: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).

    Fuentes citadas por Health Canada (2)
    • EMA 2024. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2024. [Accessed 2024 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-foeniculum-vulgare-miller-subsp-vulgare-var-vulgare-fructus_en.pdf
    • EMA 2007. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare oil. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 5 July 2007. [Accessed 2024 March 1]. Available from: http://www.e-lactancia.org/media/papers/Fennel-DS-EMEA2007.pdf

    Condición de aplicación: Essential oil and Tincture.

    Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).

    Fuentes citadas por Health Canada (1)
    • EMA 2007. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare oil. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 5 July 2007. [Accessed 2024 March 1]. Available from: http://www.e-lactancia.org/media/papers/Fennel-DS-EMEA2007.pdf

    Reacciones adversas conocidas

    Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).

    Fuentes citadas por Health Canada (2)
    • EMA 2024. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2024. [Accessed 2024 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-foeniculum-vulgare-miller-subsp-vulgare-var-vulgare-fructus_en.pdf
    • EMA 2007. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare oil. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 5 July 2007. [Accessed 2024 March 1]. Available from: http://www.e-lactancia.org/media/papers/Fennel-DS-EMEA2007.pdf

    Monografía de Health Canada del 29 de noviembre de 2024

    SWEET FENNEL -FOENICULUM VULGARE

    Vía de administración: Oral

    Precauciones y advertencias

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).

    Fuentes citadas por Health Canada (1)
    • EMA 2024. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller. subsp. vulgare var. dulce (Mill.) Batt. & Trab., Fructus London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2024. [Accessed 2024 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-foeniculum-vulgare-miller-subsp-vulgare-var-dulce-mill-batt-trab-fructus-revision-1_en.pdf

    Reacciones adversas conocidas

    Stop use if hypersensitivity/allergy occurs (EMA 2024).

    Fuentes citadas por Health Canada (1)
    • EMA 2024. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller. subsp. vulgare var. dulce (Mill.) Batt. & Trab., Fructus London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2024. [Accessed 2024 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-foeniculum-vulgare-miller-subsp-vulgare-var-dulce-mill-batt-trab-fructus-revision-1_en.pdf

    Monografía de Health Canada del 29 de noviembre de 2024

  • Huile de poisson
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    FISH OIL

    Vía de administración: Oral

    Precauciones y advertencias

    Condición de aplicación: Pain of rheumatoid arthritis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Condición de aplicación: Healthy mood balance.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.

    Monografía de Health Canada del 25 de septiembre de 2026

  • Curcuma longa
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    TURMERIC - CURCUMA LONGA - Oral

    Vía de administración: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Precauciones y advertencias

    Condición de aplicación: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    Fuentes citadas por Health Canada (2)
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.

    1 estudio citado en el texto no tiene referencia correspondiente en la monografía (véanse las anomalías en la página de fuentes).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    Fuentes citadas por Health Canada (6)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    Fuentes citadas por Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    Fuentes citadas por Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Condición de aplicación: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografía de Health Canada del 26 de septiembre de 2025

    Turmeric -CURCUMA LONGA - Topical

    Precauciones y advertencias

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindicaciones

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Monografía de Health Canada del 28 de febrero de 2025

  • Linum usitatissimum L. (Linaceae)
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    FLAXSEED - LINUM USITATISSIMUM

    Vía de administración: Oral

    Precauciones y advertencias

    Se aplica a los productos: providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    Fuentes citadas por Health Canada (1)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    Fuentes citadas por Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Condición de aplicación: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    Fuentes citadas por Health Canada (2)
    • Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
    • Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.

    Contraindicaciones

    Se aplica a los productos: providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    Fuentes citadas por Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    Fuentes citadas por Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
    • Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.

    Reacciones adversas conocidas

    Condición de aplicación: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    Fuentes citadas por Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.

    Monografía de Health Canada del 26 de julio de 2024

  • L-Glutamine
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    L-Glutamine

    Vía de administración: Oral

    Precauciones y advertencias

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Monografía de Health Canada del 30 de enero de 2026

  • Althaea officinalis
    Leer la advertencia, cuándo se aplica y los estudios citados

    Texto original oficial en inglés.

    Marshmallow - ALTHAEA OFFICINALIS - Root

    Vía de administración: Oral

    Precauciones y advertencias

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Monografía de Health Canada del 19 de diciembre de 2025

    MARSHMALLOW - ALTHAEA OFFICINALIS - LEAF

    Vía de administración: Oral

    Precauciones y advertencias

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Monografía de Health Canada del 29 de noviembre de 2024

Se refieren al ingrediente, no a este producto ni a su dosis. No sustituyen el consejo médico.

Se desconoce la fecha de la prueba de esta lista de ingredientes.

¿Ha cambiado el producto? Fotografíe el envase.

¿Alguna información inexacta o más reciente sobre este producto, sea usted lector o marca? Escriba a contact@compoatlas.com: cada corrección se publica en el registro de correcciones.

Intro para analizar, Mayús+Intro para una nueva línea